We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Advisory Committee Recommends Questcor Infantile Spasms Drug Approval
Advisory Committee Recommends Questcor Infantile Spasms Drug Approval
May 7, 2010
The FDA’s Peripheral and Central Nervous System Drugs Advisory Committee voted overwhelmingly Thursday to recommend approval of Questcor Pharmaceuticals’ sNDA
for its Acthar gel to treat infantile spasms (IS).